Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
<i>Background</i>: The higher consumption of fat and sugar are associated with obesity development and its related diseases such as non-alcoholic fatty liver disease (NAFLD). Lycopene is an antioxidant whose protective potential on fatty liver degeneration has been investigated. The aim...
主要な著者: | , , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
MDPI AG
2019-08-01
|
シリーズ: | Antioxidants |
主題: | |
オンライン・アクセス: | https://www.mdpi.com/2076-3921/8/8/276 |